menu Search
Jardiance

Jardiance Use In Pregnancy & Lactation

empagliflozin

Manufacturer:

Boehringer Ingelheim

Distributor:

Metro Drug
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Use In Pregnancy & Lactation
Pregnancy: There are limited data from the use of Empagliflozin (Jardiance) in pregnant women. Nonclinical studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure it is recommended to avoid the use of Empagliflozin (Jardiance) during pregnancy unless clearly needed.
Lactation: No data in humans are available on excretion of empagliflozin into milk. Available nonclinical data in animals have shown excretion of empagliflozin in milk. A risk to human newborns/infants cannot be excluded. It is recommended to discontinue breast feeding during treatment with Empagliflozin (Jardiance).
Fertility: No studies on the effect on human fertility have been conducted for Empagliflozin (Jardiance). Nonclinical studies in animals do not indicate direct or indirect harmful effects with respect to fertility.